Measures of dyspnea in pulmonary rehabilitation

Multidisciplinary Respiratory Medicine

Volumn 5, Issue 3, 2010, Pages 202-210

  Crisafulli, Ernesto ^a   Clini, Enrico M ^a,b  

^a Villa Pineta Hospital   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Chronic respiratory diseases; Dyspnea; Rehabilitation

Indexed keywords

CHRONIC RESPIRATORY TRACT DISEASE; CLINICAL PRACTICE; DAILY LIFE ACTIVITY; DISEASE CLASSIFICATION; DYSPNEA; EXERCISE; HUMAN; MEASUREMENT; PATHOGENESIS; PULMONARY REHABILITATION; REVIEW; VERBAL BEHAVIOR; VISUAL ANALOG SCALE; BASELINE DYSPNEA INDEX; BREATHING MUSCLE; CATEGORY RATIO 10; CHEST TIGHTNESS; MEDICAL RESEARCH COUNCIL SCALE; RATING OF PERCEIVED EXERTION; RATING SCALE; RESPIRATORY TRACT DISEASE ASSESSMENT; SYMPTOM ASSESSMENT; TRANSITIONAL DYSPNEA INDEX;

EID: 77954526838     PISSN: 1828695X     EISSN: 20496958     Source Type: Journal    
DOI: 10.1186/2049-6958-5-3-202     Document Type: Review

References (56)

1. American Thoracic Society. Dyspnea. Mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med 1999;159:321-340.
2. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais F, Morgan M, O'Donnell D, Prefault C, Reardon J, Rochester C, Schols A, Singh S, Troosters T; ATS/ERS Pulmonary Rehabilitation Writing Committee. American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation. Am J Respir Crit Care Med 2006;173:1390-1413.
3. Jones PW, Wilson RC. Cognitive aspects of breathlessness. In: Adams L, Guz A, eds. Respiratory sensations. New York: Marcel Dekker, 1996:311-339.
4. Simon PM, Schwartzstein RM, Weiss JW, Fencl V, Teghtsoonian M, Weinberger SE. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis 1990;142:1009-1014. (Pubitemid 20384351)
5. Elliott MW, Adams L, Cockcroft A, Macrae KD, Murphy K, Guz A. The language of breathlessness. Use of verbal descriptors by patients with cardiopulmonary disease. Am Rev Respir Dis 1991;144:826-832.
6. Mahler DA, Harver A, Lentine T, Scott JA, Beck K, Schwartzstein RM. Descriptors of breathlessness in cardiorespiratory diseases. Am J Respir Crit Care Med 1996;154:1357-1363.
7. Williams M, Cafarella P, Olds T, Petkov J, Frith P. The language of breathlessness differentiates between patients with COPD and age-matched adults. Chest 2008;134:489-496.
8. Paintal AS. Vagal sensory receptors and their reflex effects. Physiol Rev 1973;53:159-227.
9. Taguchi O, Kikuchi Y, Hida W, Iwase N, Satoh M, Chonan T, Takishima T. Effects of bronchoconstriction and external resistive loading on the sensation of dyspnea. J Appl Physiol 1991;71:2183-2190.
10. Mc Closkey DI. Corollary discharges: motor commands and perception. In: Brookhart JM, Mouncastle VB, eds: The nervous system. Handbook of physiology. Bethesda: American Physiological Society, 1981:2:1415-1447.
11. Killian KJ, Campbell EJ. Dyspnea. In: C. Roussos, ed. The Thorax, Part B. New York: Marcel Dekker, 1995:1709-1747.
12. O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:770-777. (Pubitemid 32881912)
13. O'Donnell DE, Bertley JC, Chau LK, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 1997;155:109-115.
14. O'Donnell DE, Chau LK, Webb KA. Qualitative aspects of exertional dyspnea in patients with interstitial lung disease. J Appl Physiol 1998;84:2000-2009.
15. O'Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Respir Dis 1993;148:1351-1357.
16. Scano G, Stendardi L, Grazzini M. Understanding dyspnoea by its language. Eur Respir J 2005;25:380-385.
17. Banzett RB, Lansing RW, Reid MB, Adams L, Brown R. "Air hunger" arising from increased PCO2 in mechanically ventilated quadriplegics. Respir Physiol 1989;76:53-67.
18. Chida M, Inase N, Ichioka M, Miyazato I, Marumo F. Ratings of perceived exertion in chronic obstructive pulmonary disease: a possible indicator for exercise training in patients with this disease. Eur J Appl Physiol Occup Physiol 1991;62:390-393.
19. Mahler DA, Ward J, Mejia-Alfaro R. Stability of dyspnea ratings after exercise training in patients with COPD. Med Sci Sports Exerc 2003;35:1083-1087. (Pubitemid 36807967)
20. Mahler DA, Harver A. A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;145:467-470.
21. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
22. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959;2:257-266.
23. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581-586.
24. de Torres JP, Pinto-Plata V, Ingenito E, Bagley P, Gray A, Berger R, Celli B. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest 2002;121:1092-1098.
25. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984;85:751-758.
26. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987;42:773-778. (Pubitemid 17142007)
27. Mahler DA, Ward J, Fierro-Carrion G, Waterman L, Lentine TF, Mejia-Alfaro R, Baird JC. Development of self-administered versions of modified baseline and transition dyspnea indexes in COPD. COPD 2004;1:165-172.
28. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988;93:580-586.
29. Guyatt GH, Thompson PJ, Berman LB, Sullivan MJ, Townsend M, Jones NL, Pugsley SO. How should we measure function in patients with chronic heart and lung disease? J Chronic Dis 1985;38:517-524.
30. Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax 2003;58:399-404.
31. Mahler DA, Tomlinson D, Olmstead EM, Tosteson AN, O'Connor GT. Changes in dyspnea, health status, and lung function in chronic airway disease. Am J Respir Crit Care Med 1995;151:61-65.
32. Witek TJ Jr, Mahler DA. Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J 2003;21:267-272.
33. Mahler DA, Witek TJ Jr. The MCID of the transition dyspnea index is a total score of one unit. COPD 2005;2:99-103.
34. Stevens SS. On the psychophysical law. Psychol Rev 1957;64:153-181.
35. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 1970;2:92-98.
36. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14:377-381.
37. Mahler DA, Horowitz MB. Perception of breathlessness during exercise in patients with respiratory disease. Med Sci Sports Exerc 1994;26:1078-1081.
38. Mador MJ, Rodis A, Magalang UJ. Reproducibility of Borg scale measurements of dyspnea during exercise in patients with COPD. Chest 1995;107:1590-1597.
39. Stulbarg MS, Carrieri-Kohlman V, Demir-Deviren S, Nguyen HQ, Adams L, Tsang AH, Duda J, Gold WM, Paul S. Exercise training improves outcomes of a dyspnea self-management program. J Cardiopulm Rehab 2002;22:109-121.
40. Foglio K, Bianchi L, Bruletti G, Battista L, Pagani M, Ambrosino N. Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. Eur Respir J 1999;13:125-132.
41. Eaton T, Garrett JE, Young P, Fergusson W, Kolbe J, Rudkin S, Whyte K. Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. Eur Respir J 2002;20:306-312.
42. Martinez FJ, de Oca MM, Whyte RI, Stetz J, Gay SE, Celli BR. Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med 1997;155:1984-1990. (Pubitemid 27256129)
43. Ries AL. Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD 2005;2:105-110.
44. Aitken RC. Measurement of feelings using visual analogue scales. Proc R Soc Med 1969;62:989-993.
45. Reardon J, Awad E, Normandin E, Vale F, Clark B, ZuWallack RL. The effect of comprehensive outpatient pulmonary rehabilitation on dyspnea. Chest 1994;105:1046-1052. (Pubitemid 24112788)
46. Horne D, Corsello P. Physical and occupational therapy for patients with chronic lung disease. Semin Respir Med 1993;14:466-481. (Pubitemid 23340459)
47. Garrod R, Bestall JC, Paul EA, Wedzicha JA, Jones PW. Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL). Respir Med 2000;94:589-596.
48. Lareau SC, Carrieri-Kohlman V, Janson-Bjerklie S, Roos PJ. Development and testing of the Pulmonary Functional Status and Dyspnea Questionnaire (PFSDQ). Heart Lung 1994;23:242-250. (Pubitemid 24175626)
49. McGavin CR., Artvinli M., Naoe H, McHardy GJ. Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. Br Med J 1978;2:241-243. (Pubitemid 8382018)
50. Garrod R, Paul EA, Wedzicha JA. An evaluation of the reliability and sensitivity of the London Chest Activity of Daily Living Scale (LCADL). Respir Med 2002;96:725-730.
51. Costi S, Crisafulli E, Antoni FD, Beneventi C, Fabbri LM, Clini EM. Effects of unsupported upper extremity exercise training in patients with COPD: a randomized clinical trial. Chest 2009;136:387-395.
52. Lareau SC, Meek PM, Roos PJ. Development and testing of the modified version of the pulmonary functional status and dyspnea questionnaire (PFSDQ-M). Heart Lung 1998;27:159-168.
53. O'Brien B, Viramontes JL. Willingness to pay: a valid and reliable measure of health state preference? Med Decis Making 1994;14:289-297.
54. Janssens JP, Breitenstein E, Rochat T, Fitting JW. Does the 'oxygen cost diagram' reflect changes in six minute walking distance in follow up studies? Respir Med 1999;93:810-815.
55. Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol 1999;52:187-192.
56. Velloso M, Stella SG, Cendon S, Silva AC, Jardim JR. Metabolic and ventilatory parameters of four activities of daily living accomplished with arms in COPD patients. Chest 2003;123:1047-1053.